Astellas Pharma Inc. Revenue Per Share for the year ending March 31, 2025: USD 7.12

Astellas Pharma Inc. Revenue Per Share is USD 7.12 for the year ending March 31, 2025, a 20.52% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Astellas Pharma Inc. Revenue Per Share for the year ending March 31, 2024 was USD 5.91, a -5.92% change year over year.
  • Astellas Pharma Inc. Revenue Per Share for the year ending March 31, 2023 was USD 6.28, a 9.10% change year over year.
  • Astellas Pharma Inc. Revenue Per Share for the year ending March 31, 2022 was USD 5.76, a -5.25% change year over year.
  • Astellas Pharma Inc. Revenue Per Share for the year ending March 31, 2021 was USD 6.08, a -5.77% change year over year.
Key Data
Date Revenue Per Share Free Cash Flow Per Share Dividend Per Share Debt to Equity Ratio